Clinical Trial Update: LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma [NA]

View source ↗

Summary

A clinical trial update for LCAR-M61S and LCAR-M61D in Relapsed/Refractory Multiple Myeloma; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• LCAR-M61D
• LCAR-M61S

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Relapsed/Refractory Multiple Myeloma | NA | Status: NOT_YET_RECRUITING